Skip to content
MedsAcross

Medicine

Methazolamide 25 mg tablet

Available on requestPrescription onlyUS FDAGeneric name

Methazolamide 25 mg tablet is a generic prescription medicine for oral use, made by 9 labelers, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.

Availability

Available on request

Export supply from India to licensed buyers

Typical lead time

On request

Counted from payment and complete documents

Shipping

Ambient

Store at 20°C to 25°C (68°F to 77°F).

Key facts

Active ingredient (INN)
Methazolamide
Brand
Sold under the generic name
Strength
25 mg
Dosage form
Tablet
Route
Oral
Packs
100 tablets, 500 tablets, 1000 tablets and 12 more
Manufacturers
Micro LabsIndiaAjanta PharmaIndiaBausch & LombBryant Ranch PrepackANI PharmaceuticalsGolden State Medical SupplyNorthStar RxPadagisPrecision Dose
Origin register
US FDA, United States
Storage
Store at 20°C to 25°C (68°F to 77°F).
Cold chain
Not required on record
Prescription status
Prescription only
Controlled substance
Not recorded as controlled
ATC code
S01EC05 Methazolamide
HS code (indicative)
3004.90Indicative only. Your customs broker confirms the final tariff code.
Marketing category
marketed
Marketed since
30 June 1993
Identifiers
RxCUI 197939, 197940DailyMed set ID 1e0e81c7-a328-4034-a6b3-4c83e9ac3a3e, 0c0ba5c7-c53e-4e29-a7ff-48fddc5a9258, c26c8834-961e-4c9c-9ad4-5db2d9419938 +7NDC 68094-908, 24208-022, 62559-240 +7Application ANDA215615, ANDA207438, ANDA040001 +2

Record updated 12 November 2026

Documents available

Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.

No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.

Packs

Packs from every labeler of this generic presentation.

PackCodeLabelerMarketed since
100 tablet in 1 bottle27241-246-01Ajanta PharmaIndia9 February 2026
500 tablet in 1 bottle42571-239-05Micro LabsIndia5 March 2019
1000 tablet in 1 bottle42571-239-10Micro LabsIndia5 March 2019
90 tablet in 1 bottle42571-239-90Micro LabsIndia5 March 2019
100 tablet in 1 bottle62559-240-01ANI Pharmaceuticals6 November 2014
1000 tablet in 1 bottle24208-022-01Bausch & Lomb2 October 2020
100 tablet in 1 bottle24208-022-10Bausch & Lomb2 October 2020
500 tablet in 1 bottle24208-022-50Bausch & Lomb2 October 2020
90 tablet in 1 bottle24208-022-90Bausch & Lomb2 October 2020
100 tablet in 1 bottle, plastic0574-0790-01Padagis30 September 2014
100 tablet in 1 bottle63629-1986-1Bryant Ranch Prepack15 January 2021
100 tablet in 1 bottle72162-1754-1Bryant Ranch Prepack25 March 2026
100 tablet in 1 bottle51407-026-01Golden State Medical Supply1 January 2018
100 tablet in 1 bottle72603-166-01NorthStar Rx30 August 2023
100 tablet in 1 bottle68094-908-50Precision Dose30 November 2023

Status by register

Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.

RegisterStatusSource
US FDAListed, marketedSource record for this pageChecked 12 November 2026
US FDAFirst approved 26 January 1959Drugs@FDA
EU (EMA)Not recorded—
India (CDSCO)Not yet confirmed against CDSCO approval lists—
United StatesRegisteredUS FDA (NDC directory, openFDA)Checked 12 November 2026

Import route

Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.

Import guides are available for 25 countries. Pick one to see its route summary.

BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides

Other strengths and forms of Methazolamide

Clinical summary

Methazolamide is a prescription medicine indicated in the treatment of ocular conditions where lowering intraocular pressure is likely to be of therapeutic benefit, such as chronic open-angle glaucoma, among other approved uses. MedsAcross supplies Methazolamide for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.

Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review

Read about Methazolamide

For healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.

Data sources

Need Methazolamide 25 mg tablet for your hospital or patient?

Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.